RAC 5.44% $1.65 race oncology ltd

Industry news, page-1688

  1. 206 Posts.
    lightbulb Created with Sketch. 62
    Perfect. Thanks Daniel. In that case would we marketing Bisantrene as both as an m6a upregulator and an FTO inhibitor?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.